 Treatment period 1:To demonstrate that switching HD subjects with a baseline haemoglobin Hb 10 gdL and 13 gdL from either subcutaneous SC or intravenous IV rHuEPO to IV darbepoetin alfa results in a mean Hb 11 gdL. 